Infectiologic differential diagnosis of chronic Lyme disease and so ...

More documents

Recommendations

Info

[155] Cover TL, Aber RC. Yersinia enterocolitica. N Enl J Med 1989; 321(1): 16-24. [156] Black RE, Slome S. Yersinia enterocolitica. Inefct Dis Clin North Am 1988; 2(3): 625-41. [157] Reed RP, Robins-Browne RM, Williams ML. Yersinia enterocolitica peritonitis. Clin Infect Dis 1997; 25(6): 1468-9. [158] Blinkhorn RJ Jr, Marino JA. Lateral pharyngeal abscess due to Yersinia enterocolitica. Am J Med 1988; 85(6): 851-2. [159] Krogstad P, Mendelman PM, Miller VL et al. Clinical and microbiologic characteristics of cutaneuous infection with Yersinia enterocolitica. J Infect Dis 1992; 165(4): 740-3. [160] Crowe M, Ashford K, Ispahani P. Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica. J Infect Microbiol 1996; 45(4): 302-9. [161] Kellogg CM, Tarakji EA, Smith M, Brown PD. Bacteremia and suppurative lymphadenitis due to Yersinia enterocolitica in a neutropenic patient who prepared chitterlings. Clin Infect Dis 1995; 21(1): 236-7. [162] van der Heijden IM, Res PC, Wilbrink B et al. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin Infect Dis 1997; 25(4): 831-7. [163] Granfors K, Jalkanen S, von Essen R et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320(4): 216-21. [164] Granfors K, Merilahti-Palo R, Luukkainen R et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998; 41(5): 855- 62. 76
[165] Leirisalo-Repo M, Suoranta H. Ten-year follow-up study of patient with Yersinia arthritis. Arthritis Rheum 1988; 31(4): 533-7. [166] Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10(2): 257-76. [167] Mäki-Ikola O, Heesemann J, Toivanen A, Granfors K. High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int 1997; 16(6): 227-9. [168] Ostroff SM. Clinical features and diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infection. UpToDate, 2009. [169] Lindblom A , Isa A, Norbeck O et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 2005; 41(8): 1201-3. [170] Lowry SM, Brent LH, Menaldino S, Kerr JR. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists. Clin Infect Dis 2005; 41(4):e42-4. [171] Nikkari S, Roivainen A, Hannonen P et al. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995; 54(7): 597-600. [172] Kühl U, Pauschinger M, Seeberg B et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112(13): 1965-70. [173] Tschöpe C, Bock CT, Kasner M et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005; 111(7): 879-86. [174] Donoso Mantke O, Nitsche A, Meyer R, Klingel K, Niedrig M. Analysing myocardial tissue from explanted hearts of heart transplant recipients and 77
Page 1 and 2:
Infectiologic differential diagnosi
Page 3 and 4:
3 Anamnistically, one has to consid
Page 5 and 6:
Table 2 LD coinfections (not tick-b
Page 7 and 8:
Table 5 Bartonellosis’ infection
Page 9 and 10:
Table 6 Main disease manifestations
Page 11 and 12:
11 Fig. 1. Erythrocytes infected wi
Page 13 and 14:
13 Bartonellae are localized in ery
Page 15 and 16:
ESR und CRP elevated Hypercalcemia
Page 18 and 19:
Table 9 Antibiotic treatment of bar
Page 20 and 21:
antibiosis is that the antibiotic i
Page 22 and 23:
The laboratory diagnostics for Chla
Page 24 and 25:
The arthritis occurs in 1% of the u
Page 26 and 27: In the differential diagnosis of Ly
Page 28 and 29: Late phase: - Reactive arthritis -
Page 30 and 31: the depiction of chronic yersiniosi
Page 32 and 33: In Yersinia-PCR-positive patients,
Page 34 and 35: - Incubation period 3 weeks - Atypi
Page 36 and 37: system, of the skin and other organ
Page 38 and 39: - Ehrlichia chaffeensis [1] - Anapl
Page 40 and 41: Since seroprevalence merely express
Page 42 and 43: B. microti is the predominant patho
Page 44 and 45: epresent a major health hazard and
Page 46 and 47: The decisive diagnostic information
Page 48 and 49: Probable: IFA IgG 1:1024 and one of
Page 50 and 51: The main manifestation of the Campy
Page 52 and 53: The term “reactive arthritis” i
Page 54 and 55: In the diagnosis of a “reactive a
Page 56 and 57: Table 27 Disease manifestations of
Page 58 and 59: addition, other pathogens discussed
Page 60 and 61: [8] Schouls LM, Van De Pol I, Rijpk
Page 62 and 63: [25] Hermanowska-Szpakowicz T, Skot
Page 64 and 65: [43] Bakken JS, Krueth JK, Lund T,
Page 66 and 67: [60] Fox LM, Wingerter S, Ahmed A e
Page 68 and 69: [80] Marra CM. Neurologic complicat
Page 70 and 71: [100] Pulliainen AT, Dehio C. Barto
Page 72 and 73: [118] Bass JW, Freitas BC, Freitas
Page 74 and 75: [137] Gaydos CA, Roblin PM, Hammers
Page 78 and 79: multi-organ donors for the presence
Page 80 and 81: [190] Straubinger RK, Straubinger A
Page 82 and 83: [208] Bitnun A, Ford-Jones E, Blase
Page 84 and 85: patients with reactive and undiffer
Page 86 and 87: [242] Appelbaum PC, Gillespie SH, B
Page 88 and 89: pneumoniae infection associated wit
Page 90 and 91: [276] Thomas NH, Collins JE, Robb S
Page 92 and 93: [294] File TM Jr, Segreti J, Dunbar
Page 94 and 95: [310] Sorvillo FJ, Lieb LE, Waterma
Page 96 and 97: henselae Isolates Collected from Ca
Page 98 and 99: [345] Raoult D, Levy PY, Harlé JR,
show all

Infectiologic differential diagnosis of chronic Lyme disease and so ...

Create successful ePaper yourself

Delete template?

Save as template?